Published Studies Related to Capastat Sulfate (Capreomycin)
Research related to Capastat Sulfate (Capreomycin)
Preparation and in vivo evaluation of a dry powder for inhalation of capreomycin. [2008.04]
Inhaled large porous particles of capreomycin for treatment of tuberculosis in a guinea pig model. [2007.08]
Preparation of large porous biodegradable microspheres by using a simple double-emulsion method for capreomycin sulfate pulmonary delivery. [2007.03.21]
Unilamellar vesicles as potential capreomycin sulfate carriers: preparation and physicochemical characterization. [2004.12.31]
UV spectroscopy and reverse-phase HPLC as novel methods to determine Capreomycin of liposomal fomulations. [2004.10.29]
Pharmacokinetics, toxicity, and efficacy of liposomal capreomycin in disseminated Mycobacterium avium beige mouse model. [1994.12]
Other possibly related research studies
Treatment outcome of multidrug-resistant tuberculosis among Vietnamese immigrants. [2005.02]
[A case of pulmonary multiresistant Mycobacterium bovis tuberculosis in Madagascar] [2003]
[Pulmonary disease caused by nontuberculous mycobacteria after allogeneic hematopoietic stem cell transplantation--a case report and literature review] [2004.08]
A decade surveillance study of Mycobacterium xenopi disease and antimicrobial susceptibility levels in a reference teaching hospital of northern Italy: HIV-associated versus non-HIV-associated infection. [2004.07]
Hypokalemia among patients receiving treatment for multidrug-resistant tuberculosis. [2004.03]
Multidrug-resistant tuberculosis in pregnancy: case report and review of the literature. [2003.03]
Activities of moxifloxacin alone and in combination with other antimicrobial agents against multidrug-resistant Mycobacterium tuberculosis infection in BALB/c mice. [2003.01]
[Pulmonary infection caused by Mycobacterium szulgai: a case report] [2002.05]
Treatment and prevention of multidrug-resistant tuberculosis. [1999.10]
Multicenter laboratory validation of susceptibility testing of Mycobacterium tuberculosis against classical second-line and newer antimicrobial drugs by using the radiometric BACTEC 460 technique and the proportion method with solid media. [1999.10]
The safety of antituberculosis medications during breastfeeding. [1998.12]
[Surgical treatment of patients with multi-resistant pulmonary tuberculosis--case reports] [1997]
Prevention and treatment of drug-resistant tuberculosis. [1996.10.01]
Clinical manifestation and outcome of tuberculosis in children with acquired immunodeficiency syndrome. [1996.05]
Origin and interstate spread of a New York City multidrug-resistant Mycobacterium tuberculosis clone family. [1996.02.14]
Tuberculosis susceptibility patterns, predictors of multidrug resistance, and implications for initial therapeutic regimens at a New York City hospital. [1994.10.10]
Antimycobacterial drugs. [1994.06]
Hepatotoxicity associated with acetaminophen usage in patients receiving multiple drug therapy for tuberculosis. [1994.02]
Therapy of multidrug-resistant tuberculosis: lessons from studies with mice. [1993.11]
Pharmacology of the antimycobacterial drugs. [1993.11]
Renal magnesium wasting associated with therapeutic agents. [1991]
Immunosuppression by gramicidin S of experimental autoimmune uveoretinitis, pinealitis and autoimmune encephalomyelitis. [1990.09]
[Interactions of antitubercular drugs] [1988]
The efficacy of certain anti-tuberculosis drugs is affected by binding to alpha-1-acid glycoprotein. [2006.06]
Evaluation of MGIT 960-based antimicrobial testing and determination of critical concentrations of first- and second-line antimicrobial drugs with drug-resistant clinical strains of Mycobacterium tuberculosis. [2006.03]
Multicenter laboratory validation of the BACTEC MGIT 960 technique for testing susceptibilities of Mycobacterium tuberculosis to classical second-line drugs and newer antimicrobials. [2006.03]
A community-based TB drug susceptibility study in Mimika District, Papua Province, Indonesia. [2006.02]
[Tuberculosis caused by XDR resistant Mycobacterium tuberculosis in Poland. Microbiological and molecular analysis] [2007]
Impact of extensive drug resistance on treatment outcomes in non-HIV-infected patients with multidrug-resistant tuberculosis. [2007.11.15]
[Extensively drug-resistant tuberculosis] [2008.02]
Extensively drug-resistant tuberculosis in california, 1993-2006. [2008.08.15]
Resistance to second-line injectables and treatment outcomes in multidrug-resistant and extensively drug-resistant tuberculosis cases. [2008.06]
High levels of resistance to second-line anti-tuberculosis drugs among prisoners with pulmonary tuberculosis in Georgia. [2008.05]
|
